Literature DB >> 25523819

Knock-in mouse model of alternating hemiplegia of childhood: behavioral and electrophysiologic characterization.

Arsen S Hunanyan1, Nina A Fainberg, Molly Linabarger, Eric Arehart, A Soren Leonard, Syed M Adil, Ashley R Helseth, Amanda K Swearingen, Stacy L Forbes, Ramona M Rodriguiz, Theodore Rhodes, Xiaodi Yao, Nadine Kibbi, Daryl W Hochman, William C Wetsel, Ute Hochgeschwender, Mohamad A Mikati.   

Abstract

OBJECTIVES: Mutations in the ATP1α3 subunit of the neuronal Na+/K+-ATPase are thought to be responsible for seizures, hemiplegias, and other symptoms of alternating hemiplegia of childhood (AHC). However, the mechanisms through which ATP1A3 mutations mediate their pathophysiologic consequences are not yet understood. The following hypotheses were investigated: (1) Our novel knock-in mouse carrying the most common heterozygous mutation causing AHC (D801N) will exhibit the manifestations of the human condition and display predisposition to seizures; and (2) the underlying pathophysiology in this mouse model involves increased excitability in response to electrical stimulation of Schaffer collaterals and abnormal predisposition to spreading depression (SD).
METHODS: We generated the D801N mutant mouse (Mashlool, Mashl+/-) and compared mutant and wild-type (WT) littermates. Behavioral tests, amygdala kindling, flurothyl-induced seizure threshold, spontaneous recurrent seizures (SRS), and other paroxysmal activities were compared between groups. In vitro electrophysiologic slice experiments on hippocampus were performed to assess predisposition to hyperexcitability and SD.
RESULTS: Mutant mice manifested a distinctive phenotype similar to that of humans with AHC. They had abnormal impulsivity, memory, gait, motor coordination, tremor, motor control, endogenous nociceptive response, paroxysmal hemiplegias, diplegias, dystonias, and SRS, as well as predisposition to kindling, to flurothyl-induced seizures, and to sudden unexpected death. Hippocampal slices of mutants, in contrast to WT animals, showed hyperexcitable responses to 1 Hz pulse-trains of electrical stimuli delivered to the Schaffer collaterals and had significantly longer duration of K+-induced SD responses. SIGNIFICANCE: Our model reproduces the major characteristics of human AHC, and indicates that ATP1α3 dysfunction results in abnormal short-term plasticity with increased excitability (potential mechanism for seizures) and a predisposition to more severe SD responses (potential mechanism for hemiplegias). This model of the human condition should help in understanding the molecular pathways underlying these phenotypes and may lead to identification of novel therapeutic strategies of ATP1α3 related disorders and seizures. Wiley Periodicals, Inc.
© 2014 International League Against Epilepsy.

Entities:  

Keywords:  ATP1A3; Alternating hemiplegia of childhood; D801N; Epilepsy; Hippocampus; Spreading depression

Mesh:

Substances:

Year:  2014        PMID: 25523819     DOI: 10.1111/epi.12878

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  32 in total

1.  Polysomnography Findings and Sleep Disorders in Children With Alternating Hemiplegia of Childhood.

Authors:  Sujay Kansagra; Ryan Ghusayni; Bassil Kherallah; Talha Gunduz; Melissa McLean; Lyndsey Prange; Richard M Kravitz; Mohamad A Mikati
Journal:  J Clin Sleep Med       Date:  2019-01-15       Impact factor: 4.062

Review 2.  Sodium pump regulation of locomotor control circuits.

Authors:  Laurence D Picton; HongYan Zhang; Keith T Sillar
Journal:  J Neurophysiol       Date:  2017-05-24       Impact factor: 2.714

Review 3.  Diagnosis and Treatment of Alternating Hemiplegia of Childhood.

Authors:  Melanie Masoud; Lyndsey Prange; Jeffrey Wuchich; Arsen Hunanyan; Mohamad A Mikati
Journal:  Curr Treat Options Neurol       Date:  2017-02       Impact factor: 3.598

4.  A Transgenic Mouse Model to Selectively Identify α3 Na,K-ATPase Expressing Cells in the Nervous System.

Authors:  Maxim Dobretsov; Abdallah Hayar; Neriman T Kockara; Maxim Kozhemyakin; Kim E Light; Pankaj Patyal; Dwight R Pierce; Patricia A Wight
Journal:  Neuroscience       Date:  2018-07-19       Impact factor: 3.590

5.  Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations.

Authors:  Mary E Moya-Mendez; David M Mueller; Milton Pratt; Melanie Bonner; Courtney Elliott; Arsen Hunanyan; Gary Kucera; Cheryl Bock; Lyndsey Prange; Joan Jasien; Karen Keough; Vandana Shashi; Marie McDonald; Mohamad A Mikati
Journal:  Epilepsy Behav       Date:  2021-01-23       Impact factor: 2.937

6.  Adeno-Associated Virus-Mediated Gene Therapy in the Mashlool, Atp1a3Mashl/+, Mouse Model of Alternating Hemiplegia of Childhood.

Authors:  Arsen S Hunanyan; Boris Kantor; Ram S Puranam; Courtney Elliott; Angela McCall; Justin Dhindsa; Promila Pagadala; Keri Wallace; Jordan Poe; Talha Gunduz; Aravind Asokan; Dwight D Koeberl; Mai K ElMallah; Mohamad A Mikati
Journal:  Hum Gene Ther       Date:  2021-02-12       Impact factor: 5.695

7.  Intermediate Phenotypes of ATP1A3 Mutations: Phenotype-Genotype Correlations.

Authors:  Pichet Termsarasab; Amy C Yang; Steven J Frucht
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-09-16

8.  Characterization of cognitive deficits in mice with an alternating hemiplegia-linked mutation.

Authors:  Greer S Kirshenbaum; James Dachtler; John C Roder; Steven J Clapcote
Journal:  Behav Neurosci       Date:  2015-10-26       Impact factor: 1.912

Review 9.  Managing Brain Extracellular K(+) during Neuronal Activity: The Physiological Role of the Na(+)/K(+)-ATPase Subunit Isoforms.

Authors:  Brian Roland Larsen; Anca Stoica; Nanna MacAulay
Journal:  Front Physiol       Date:  2016-04-22       Impact factor: 4.566

10.  Spontaneously Fluctuating Motor Cortex Excitability in Alternating Hemiplegia of Childhood: A Transcranial Magnetic Stimulation Study.

Authors:  William M Stern; Mahalekshmi Desikan; Damon Hoad; Fatima Jaffer; Gionata Strigaro; Josemir W Sander; John C Rothwell; Sanjay M Sisodiya
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.